Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
26.45
-1.95 (-6.88%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $57.71. The average 1-year stock price forecast is 118.23% higher than the current stock price, while the lowest is $48 (+81.51%) and the highest is $75 (+183.61%).
Price Target: $57.71 (+118.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $75 | Buy | Reiterates | $75 | +183.61% | Jul 13, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $55 | Buy | Maintains | $55 | +107.98% | May 15, 2026 |
| Lake Street | Lake Street | Buy Maintains $50 | Buy | Maintains | $50 | +89.07% | May 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $62 → $66 | Buy | Reiterates | $62 → $66 | +149.57% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +126.89% | May 15, 2026 |
Financial Forecast
Revenue This Year
63.92M
from 16.80M
Increased by 280.56%
Revenue Next Year
121.18M
from 63.92M
Increased by 89.59%
EPS This Year
-10.66
from -13.29
EPS Next Year
-2.13
from -10.66
EPS and Forward PE are based on non-GAAP adjusted numbers.